November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
M. Bilal Abid about development of bispecific antibodies across community practices
Oct 15, 2024, 14:07

M. Bilal Abid about development of bispecific antibodies across community practices

M. Bilal Abid posted on LinkedIn:

“My vision on broader development of bispecific antibodies across community practices!”

See Further.

Muhammad Bilal Abid is a Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center. He has also serves as a Senior Clinical Fellow in Hematology/Oncology at The University of Texas Health Science Center at Houston (UTHealth Houston). His work focuses on scientific research, clinical trials, and the development of protocols related to Investigational New Drug (IND) and New Drug Application (NDA) processes in hematology/oncology and cellular therapy.